Accessibility Menu
 
Vericel logo

Vericel

(NASDAQ) VCEL

Current Price$35.77
Market Cap$1.82B
Since IPO (1997)-97%
5 Year-38%
1 Year-13%
1 Month+14%

Vericel Financials at a Glance

Market Cap

$1.82B

Revenue (TTM)

$276.26M

Net Income (TTM)

$16.52M

EPS (TTM)

$0.31

P/E Ratio

116.34

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Price

$35.77

Volume

0

Open

$35.49

Previous Close

$35.77

Daily Range

$35.05 - $36.00

52-Week Range

$28.95 - $45.97

VCEL: Motley Fool Moneyball Superscore

68

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vericel

Industry

Biotechnology

Employees

398

CEO

Dominick C. Colangelo

Headquarters

Cambridge, MA 02139, US

VCEL Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

4%

Net Income Margin

6%

Return on Equity

5%

Return on Capital

3%

Return on Assets

3%

Earnings Yield

0.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.82B

Shares Outstanding

50.93M

Volume

0

Short Interest

0.00%

Avg. Volume

573.93K

Financials (TTM)

Gross Profit

$205.60M

Operating Income

$11.04M

EBITDA

$30.29M

Operating Cash Flow

$51.91M

Capital Expenditure

$27.16M

Free Cash Flow

$24.75M

Cash & ST Invst.

$137.50M

Total Debt

$98.27M

Vericel Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$92.92M

+23.3%

Gross Profit

$73.13M

+25.0%

Gross Margin

78.70%

N/A

Market Cap

$1.82B

N/A

Market Cap/Employee

$5.11M

N/A

Employees

357

N/A

Net Income

$23.24M

+17.3%

EBITDA

$27.53M

+27.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$39.23M

+126.0%

Accounts Receivable

$84.63M

+37.9%

Inventory

$17.56M

+1.1%

Long Term Debt

$84.18M

-6.0%

Short Term Debt

$14.09M

+52.2%

Return on Assets

3.39%

N/A

Return on Invested Capital

2.52%

N/A

Free Cash Flow

$802.00K

-90.5%

Operating Cash Flow

$15.01M

-32.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NUVBNuvation Bio Inc.
$5.12+0.79%
HRMYHarmony Biosciences Holdings, Inc.
$29.53-1.53%
OCULOcular Therapeutix, Inc.
$9.52-3.06%
AUPHAurinia Pharmaceuticals Inc.
$15.96-0.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.29-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$58.08-0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$56.91+0.01%
POETPoet Technologies
$8.59+0.18%

Questions About VCEL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.